May 2024

Doheny in the Spotlight at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting


As one of the world’s foremost vision research institutions, Doheny Eye Institute was well represented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, held May 5-9 in Seattle. Not only were Doheny scientists selected to present their latest research in more than 28 paper and poster presentations, but our own SriniVas Sadda, MD, was officially named president of ARVO at the conclusion of this year’s meeting. Additionally, multiple events and an engaging exhibitor presence helped Doheny connect with a wide variety of attendees. Read more here.

Marissa Goldberg and Deborah Ferrington, PhD, Featured in the Los Angeles Business Journal’s Women of Influence: Health Care 2024


We are proud to share that for the second consecutive year, Doheny CEO Marissa Goldberg and Chief Scientific Officer Deborah Ferrington, PhD, were selected by the Los Angeles Business Journal as Women of Influence: Health Care 2024.

This special issue highlights stellar health industry stewards in the Los Angeles region who have made an impact on the profession and on the community.


Click here to read the piece featuring Ms. Goldberg


    Click here to read the piece featuring Dr. Ferrington

      Join Doheny Eye Institute for the Annual Planned Giving Luncheon on June 6

      Doheny Eye Institute invites you to join us for the annual Planned Giving Luncheon on Thursday, June 6 beginning at 11:30 a.m. at our Pasadena campus. Dr. SriniVas Sadda will be one of our featured speakers, and he will share some of the latest advances in artificial intelligence (AI) and imaging and how this will impact the future of eye care and vision research. Additionally, we will have planning experts on hand to help provide insights and support as you plan your future legacy.

      RSVP by Thursday, May 30 to Heidi Simpson-Sandoval at (323) 342-7104 or email .

      Doheny in the News: Medika Life


      Recently, Doheny Eye Institute Chief Scientific Officer Deborah Ferrington, PhD, penned an article for Medika Life titled, “Research Drives AMD Treatments Toward Targeted Therapies.” The piece explores the urgent need to discover therapies that can effectively address age-related macular degeneration (AMD), and explores the work being undertaken by researchers to learn more about the disease, the challenges they face, and more. Medika Life is an online health information platform dedicated to bringing scientifically-validated and actionable health information to the world. You can read Dr. Ferrington’s article here.


      Share this with your friends!